medigraphic.com

2001, Number 1

<< Back Next >>

Cir Cir 2001; 69 (1)

Morbidity and mortality of rhino-orbitary mucormycosis after timely treatment

Barrón-Soto MA, Campos-Navarro la, Barrón-Rivas ma, Real-Villa CAp

Language: Spanish
References: 16
Page: 8-11
PDF size: 31.00 Kb.


ABSTRACT

Our objective was to assess the morbidity and mortality of rhino-orbitary mucormicosis. We evaluated 24 consecutive patients (38 - 65 years of age). All patients had a history of diabetes mellitus. Some also had a history of alcoholic liver disease, kidney disease, arterial hypertension, and arthritis. Clinical and radiologic evaluation showed necrosis and destruction; treatment was performed with amphotericin and surgery after mucormicosis was diagnosed. Although timely treatment was performed, we observed a mortality rate of 56%.


REFERENCES

  1. Escajadillo JR. Infección de nariz y senos paranasales. In: Escajadillo JR, editors. Oídos, nariz y garganta y cirugía de cabeza y cuello. México, D.F.: Edit. Manual Moderno 1991: 318-19.

  2. Wilson WR, Montgomery WM. Infecciones y granulomas de las vías aéreas nasales y senos paranasales. In: Paparella MM, editor. Otorrinolaringología. Argentina: Editorial Médica Panamericana. 1990: 1965.

  3. Johnson JT, Weymuller EA, Rice DH. Infections, surgical management of infections and inflammatory disease. In: Cummings CW editor. Otolaryngology, head and neck surgery. US. Mosby Year Book, Inc. 1993: 931-33, 956.

  4. Perolada VJ, Morera PC, Blanes JM, et al. Mucormycosis of the paranasal sinuses. Rev Laryngol-Otol-Rhinol Bord 1996; 117: 51-2.

  5. Zapater E, Armengot M, Campos A, et al. Invasive fungal sinusitis in immunosuppressed patients. Report of three cases. Acta Otorhinolaryngol Belg 1996; 50: 137-42.

  6. Ambrosio A, Alterio F. A case of rhino-orbital mucormycosis in a subject with compensated diabetes mellitus. Minerva Stomatol 1994; 43: 543-8.

  7. Weaver LK. Hypoxemia during hyperbaric oxygen therapy. Chest 1994; 105: 1270.

  8. Yohai RA, Bullock JD, Aziz AA, Market RJ. Survival factors in rhinoorbital cerebral mucormycosis. Surv Ophthalmol 1994; 39: 3-22.

  9. Jurgens MA, Martínez UV, Peiro CG, et al. Mucormycosis of paranasal sinuses: benign type. Report of one case. Acta Otorrinolaringol Esp 1994; 45: 117-20.

  10. Kopke RD, Jackson RL, Holds JB. Rhinitis. Orbital tumors. In: Bailey BJ, editor. Head and neck surgery otolaryngology. Philadelphia, Pa, USA. JB Lippincott Company. 1993: 284, 1114-6.

  11. Kajs WM. Hyperbaric oxygen therapy for rhinocerebral fungal infection. J Neurosci-Nurs 1995; 27: 174-81.

  12. Duque F, González N, Lopera C. Manifestaciones otorrinolaringológicas de la mucormicosis, estudio de seis casos. Acta Otorrinolaringol Esp 1996; 47: 291-4.

  13. Russell G. Isolated cerebral mucormycosis. Case report and therapeutic considerations. Neurosurgery 1994; 34: 174-7.

  14. Bessler SC, Hailemariam S, Gammert C. Rhino-orbital mucormycosis: Surgical aspect. Otorhinolaryngol Relat Spec 1994; 56: 224-6.

  15. Nussbam ES, Walter AH. Rhinocerebral mucormycosis: changing patterns of disease. Surg Neurol 1994; 41: 152-6.

  16. Loré JM. Los senos y el maxilar superior. In: Atlas of head and neck surgery. Philadelphia. PA, USA: WB Saunders. 1988: 157-167.




2020     |     www.medigraphic.com